Page last updated: 2024-11-05

trigonelline and Acute Confusional Senile Dementia

trigonelline has been researched along with Acute Confusional Senile Dementia in 5 studies

trigonelline: in hydra among other organisms; RN given refers to hydroxide inner salt; structure
N-methylnicotinic acid : A pyridinium ion consisting of nicotinic acid having a methyl substituent on the pyridine nitrogen.
N-methylnicotinate : An iminium betaine that is the conjugate base of N-methylnicotinic acid, arising from deprotonation of the carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Trigonelline is an alkaloid found in medicinal plants such as fenugreek seeds and coffee beans with neuroprotective potential and according to existing evidences, a favorable agent for treatment of neurodegenerative disorders."1.51Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms. ( Baluchnejadmojarad, T; Fahanik-Babaei, J; Nikbakht, F; Roghani, M, 2019)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Zia, SR1
Wasim, M1
Ahmad, S1
Farid, MM1
Yang, X1
Kuboyama, T1
Tohda, C1
Chowdhury, AA1
Gawali, NB1
Bulani, VD1
Kothavade, PS1
Mestry, SN1
Deshpande, PS1
Juvekar, AR1
Fahanik-Babaei, J1
Baluchnejadmojarad, T1
Nikbakht, F1
Roghani, M1
Makowska, J1
Szczesny, D1
Lichucka, A1
Giełdoń, A1
Chmurzyński, L1
Kaliszan, R1

Other Studies

5 other studies available for trigonelline and Acute Confusional Senile Dementia

ArticleYear
Unlocking therapeutic potential of trigonelline through molecular docking as a promising approach for treating diverse neurological disorders.
    Metabolic brain disease, 2023, Volume: 38, Issue:8

    Topics: Alkaloids; Alzheimer Disease; Humans; Molecular Docking Simulation; Nervous System Diseases

2023
Trigonelline recovers memory function in Alzheimer's disease model mice: evidence of brain penetration and target molecule.
    Scientific reports, 2020, 10-02, Volume: 10, Issue:1

    Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Atroph

2020
In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:2

    Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Br

2018
Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.
    Metabolic brain disease, 2019, Volume: 34, Issue:1

    Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cytokines; Disease Model

2019
Preliminary studies on trigonelline as potential anti-Alzheimer disease agent: determination by hydrophilic interaction liquid chromatography and modeling of interactions with beta-amyloid.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014, Oct-01, Volume: 968

    Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Biological Availability; Blood-Brain Barrier; B

2014